Condition
Elderly Patients (>65 Years)
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07119424RecruitingPrimary
Multidisciplinary Dissection of Renal and Metabolic Effects of Glyfozines on Elderly Patients: From Molecular Aspects to Clinical Indications
NCT07086300Not ApplicableRecruitingPrimary
Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC
NCT06973967Not Yet Recruiting
Low- vs. Normal-Flow Anesthesia and Delirium After Hip Fracture in the Elderly
Showing all 3 trials